Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups
about
Autologous blood and platelet rich plasma injection therapy for lateral elbow painA New Economic Method for Preparing Platelet-rich PlasmaProblems associated with alloplastic materials in rhinoplastyAutologous platelet-rich plasma promotes endometrial growth and improves pregnancy outcome during in vitro fertilization.Effects of Platelet-Rich Plasma (PRP) on a Model of Renal Ischemia-Reperfusion in Rats.Clinical application of adipose stem cells in plastic surgery.Platelet-Rich Plasma Promotes Axon Regeneration, Wound Healing, and Pain Reduction: Fact or Fiction.Growth Factor Release from Lyophilized Porcine Platelet-Rich Plasma: Quantitative Analysis and Implications for Clinical Applications.Quantification of growth factors in different platelet concentrates.The use of platelet-rich plasma to augment conservative and surgical treatment of hip and pelvic disorders.Easy-to-prepare autologous platelet-rich plasma in the treatment of refractory corneal ulcers.Extracorporeal Shockwave Therapy Increases Growth Factor Release from Equine Platelet-Rich Plasma In Vitro.Reconstruction of cranial cruciate ligament in rabbits using polyester implants saturated with PRP, antlerogenic stem cells MIC-1 and their homogenate.Platelet-Rich Plasma Powder: A New Preparation Method for the Standardization of Growth Factor Concentrations.Platelet-rich plasma for tissue regeneration can be stored at room temperature for at least five days.The Fountain of Youth: A Tale of Parabiosis, Stem Cells, and Rejuvenation.The use of platelet-rich plasma in the treatment of greater trochanteric pain syndrome: a systematic literature reviewPlatelet‑rich fibrin exudate promotes the proliferation and osteogenic differentiation of human periodontal ligament cells in vitro
P2860
Q24200860-381EAC01-C197-4937-9B76-C0114649E58AQ34239758-4677B785-A270-4CBE-ACAB-2A26852478D4Q34384400-957E32B4-6385-4212-9D74-48DDFC36DC36Q35173857-9BBB0E7C-DAFC-4510-89C2-AAE3D2F48140Q36110083-8CA5F0A4-E119-4073-8001-429C1C34FDDBQ38206197-FCA25424-B367-478D-96E6-9764D585BD73Q38517840-4D52C925-EC7B-4E42-89A2-AE39625E7243Q38620035-54921E4A-0CB2-4E3F-A33F-EE5DC9512369Q38748309-8E57117F-6774-4684-9465-FAB386A08D04Q39076186-87042598-8D69-48C3-B134-6A43D6C3B737Q42231406-236F71ED-8A4C-4624-AF6B-C57A30D29FC5Q47117747-748207B2-3A0B-46F2-880B-261278A1E7D7Q48267694-4B138048-2A56-4EBC-9A0C-1B8D67EF62F7Q51035229-8C22A0C6-DFD8-4198-9690-AAE5FDF05385Q51776961-834CC430-3D43-4C14-BDFE-7B787B3D9076Q51786747-631836A2-B93D-469A-B618-C5F978AB515EQ58563890-EDE67A57-6DDE-4E64-AF66-AF9A70CAAFA4Q58752955-1F8F6EF9-50C9-47E6-B033-C5EEEB0D52CB
P2860
Platelet-rich plasma: quantitative assessment of growth factor levels and comparative analysis of activated and inactivated groups
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Platelet-rich plasma: quantita ...... tivated and inactivated groups
@en
Platelet-rich plasma: quantita ...... ivated and inactivated groups.
@nl
type
label
Platelet-rich plasma: quantita ...... tivated and inactivated groups
@en
Platelet-rich plasma: quantita ...... ivated and inactivated groups.
@nl
prefLabel
Platelet-rich plasma: quantita ...... tivated and inactivated groups
@en
Platelet-rich plasma: quantita ...... ivated and inactivated groups.
@nl
P2093
P2860
P1476
Platelet-rich plasma: quantita ...... tivated and inactivated groups
@en
P2093
Byung Chae Cho
Ho Yun Chung
Jun Ho Shin
Jung Dug Yang
Kang Young Choi
O Hyun Kwon
Taek Kyun Kim
Young Kyoo Cho
P2860
P304
P356
10.5999/APS.2013.40.5.530
P577
2013-09-13T00:00:00Z